Agenda
Current Paradigms in Cardiovascular Care of the Cancer Patient / Survivor
Friday, October 3, 2025 | Waldorf Astoria Chicago
| Time | Session / Description |
|---|---|
| 7:00–7:55 AM | Registration & Breakfast Check-in and light breakfast |
| 7:25–7:55 AM | 1st Product Theatre Industry-sponsored session |
| 7:55–8:00 AM | Welcome & Introduction Opening remarks – Dr. Tochukwu Okwuosa |
| SESSION I: The Necessity for Cardio-Oncology | |
| 8:00–8:15 AM | Where Heart Disease and Cancer Intersect (Cardiology Perspective) |
| 8:15–8:30 AM | Where Cancer and Heart Disease Intersect (Oncology Perspective) |
| 8:30–8:45 AM | Cardio-Oncology: Forward and Reverse, An Overview |
| 8:45–9:05 AM | Panel Discussion – Interactive Q&A |
| 9:05–9:15 AM | Short Break |
| SESSION II: Cardiovascular Risks of Oncological Therapies | |
| 9:15–9:30 AM | Culprit Chemotherapies and Cardiotoxicity: Anthracyclines and Beyond |
| 9:30–9:45 AM | Radiation-Associated Cardiotoxicity: Past, Present & Future |
| 9:45–10:00 AM | Targeted Therapies: The Heart as a Target? |
| 10:00–10:10 AM | Short Break |
| 10:10–10:25 AM | Stem Cell Transplant and CAR-T Cell Therapy |
| 10:25–10:40 AM | Endocrine and Hormone Therapies: The Forgotten Long-Term Cancer Therapies |
| 10:40–11:00 AM | Panel Discussion – Interactive Q&A |
| SESSION III: Risk Assessment in Cardio-Oncology | |
| 11:00–11:15 AM | Biomarkers in Risk Assessment |
| 11:15–11:30 AM | Imaging for Risk: Beyond MUGA and 2D Echo |
| 11:30 AM–12:45 PM | Poster Presentations & Lunch Fitzgerald Salon – Networking + CME credit |
| 12:05–12:35 PM | Immune Checkpoint Inhibitors and the Heart (Non-CME session) |
| 1:00–1:15 PM | 2nd Product Theatre Industry-sponsored session |
| 1:15–1:30 PM | Risk Assessment Prior to Stem Cell Transplant and CAR-T Therapy |
| 1:30–1:50 PM | Case Presentation: Cardio-Oncology Risk Tools in Use |
| 1:50–2:00 PM | Panel Discussion |
| SESSION IV: Management Considerations & Future Directions | |
| 2:00–2:15 PM | Medical Therapy & Anticoagulation During Cancer Treatment |
| 2:15–2:30 PM | Cancer Survivorship: Definitions and Management |
| 2:30–2:45 PM | Big Data, Registries, and Precision Cardio-Oncology |
| 2:45–3:00 PM | Panel Discussion |
| 3:00–3:10 PM | Guest Speaker – Dr. Rupa Sanghani |
| 3:10 PM onward | Reception & Poster Awards Drinks, hors d’oeuvres, networking, and closing remarks – Dr. Tochukwu Okwuosa |
Current Paradigms in Cardiovascular Care of the Cancer Patient / Survivor
Friday, October 3, 2025 | Waldorf Astoria Chicago
7:00–7:55 AM
Registration & Breakfast
Check-in and light breakfast served
7:25–7:55 AM
Product Theatre I
Industry-sponsored session
7:55–8:00 AM
Welcome & Opening Remarks
Dr. Tochukwu Okwuosa
SESSION I: The Necessity for Cardio-Oncology
8:00–9:15 AM
8:00–8:15 AM — Where Heart Disease and Cancer Intersect (Cardiology Perspective)
8:15–8:30 AM — Where Cancer and Heart Disease Intersect (Oncology Perspective)
8:30–8:45 AM — Cardio-Oncology: Forward and Reverse, An Overview
8:45–9:05 AM — Panel Discussion & Q&A
9:05–9:15 AM — Short Break
SESSION II: Cardiovascular Risks of Oncological Therapies
9:15–11:00 AM
9:15–9:30 AM — Culprit Chemotherapies and Cardiotoxicity: Anthracyclines and Beyond
9:30–9:45 AM — Radiation-Associated Cardiotoxicity: Past, Present & Future
9:45–10:00 AM — Targeted Therapies: The Heart as a Target?
10:00–10:10 AM — Short Break
10:10–10:25 AM — Stem Cell Transplant and CAR-T Cell Therapy
10:25–10:40 AM — Endocrine and Hormone Therapies: The Forgotten Long-Term Cancer Therapies
10:40–11:00 AM — Panel Discussion & Q&A
SESSION III: Risk Assessment in Cardio-Oncology
11:00 AM–2:00 PM
11:00–11:15 AM — Biomarkers in Risk Assessment
11:15–11:30 AM — Imaging for Risk: Beyond MUGA and 2D Echo
11:30 AM–12:45 PM
Poster Presentations & Networking Lunch
Located in Fitzgerald Salon – Includes CME credit
12:05–12:35 PM — The New Era of Immunotherapies: Immune Checkpoint Inhibitors and the Heart (Non-CME session)
1:00–1:15 PM
Product Theatre II
Industry-sponsored session
1:15–1:30 PM — Risk Assessment Prior to Stem Cell Transplant and CAR-T Therapy
1:30–1:50 PM — Case Presentation: Cardio-Oncology Risk Tools in Use
1:50–2:00 PM — Panel Discussion
SESSION IV: Management Considerations & Future Directions
2:00–3:30 PM
2:00–2:15 PM — Medical Therapy & Anticoagulation During Cancer Treatment
2:15–2:30 PM — Cancer Survivorship: Definitions and Management
2:30–2:45 PM — Big Data, Registries, and Precision Cardio-Oncology
2:45–3:00 PM — Panel Discussion
3:00–3:10 PM — Special Speaker: Dr. Rupa Sanghani
3:10 PM onward
Reception & Poster Awards
Drinks, hors d’oeuvres, networking, and closing remarks by Dr. Tochukwu Okwuosa
Let me know if you’d like a version formatted as HTML, a downloadable PDF, or styled for event registration pages.
Current Paradigms in Cardiovascular Care
of the Cancer Patient / Survivor
Friday, October 3, 2025 | Waldorf Astoria Chicago
7:00–7:55 AM Registration & Breakfast Check-in and light breakfast
7:25–7:55 AM 1st Product Theatre
7:55–8:00 AM Welcome & Introduction – Dr. Tochukwu Okwuosa Opening Remarks
8:00–9:15 AM SESSION I: The Necessity for Cardio-Oncology
8:00–8:15 AM Where Heart Disease and Cancer Intersect (Cardiology Perspective) Lecture
8:15–8:30 AM Where Cancer and Heart Disease Intersect (Oncology Perspective) Lecture
8:30–8:45 AM Cardio-Oncology: Forward and Reverse, An Overview Lecture
8:45–9:05 AM Panel Discussion Q&A format
9:05–9:15 AM Short Break
9:15–10:10 AM SESSION II: Cardiovascular Risks of Various Oncological Therapies
9:15–9:30 AM Culprit Chemotherapies and Cardiotoxicity: Anthracyclines and Beyond Lecture
9:30–9:45 AM Radiation-Associated Cardiotoxicity: Lessons from Past, Present & Future Lecture
9:45–10:00 AM Targeted Therapies for Cancer Treatment: The Heart as a Target? Lecture
10:00–10:10 AM Short Break
10:10–10:25 AM Stem Cell Transplant and CAR-T Cell Therapy Lecture
10:25–10:40 AM Endocrine and Hormone Therapies: The Forgotten Long-Term Cancer Therapies Lecture
10:40–11:00 AM Panel Discussion Q&A format
11:00 AM–2:00 PM SESSION III: Risk Assessment in Cardio-Oncology
11:00–11:15 AM Biomarkers in Risk Assessment Lecture
11:15–11:30 AM Imaging for Risk: Beyond MUGA and 2D Echo Lecture
11:30–12:45 PM Poster Presentations and Lunch in Fitzgerald Salon, Networking + CME credit
12:05–12:35 PM The New Era of Immunotherapies: Immune Checkpoint Inhibitors and the Heart Non-CME session
1:00–1:15 PM 2nd Product Theatre Industry-Sponsored
1:15–1:30 PM Risk Assessment Prior to Stem Cell Transplant and CAR-T Therapy Lecture
1:30–1:50 PM Case Presentation: Cardio-Oncology Risk Tools in Use Case Study
1:50–2:00 PM Panel Discussion
2:00–3:30 PM SESSION IV: Management Considerations & Future Directions
2:00–2:15 PM Medical Therapy & Anticoagulation During Cancer Treatment Lecture
2:15–2:30 PM Cancer Survivorship: Definitions and Management Lecture
2:30–2:45 PM Big Data, Registries, and Precision Cardio-Oncology Lecture
2:45–3:00 PM Panel Discussion
3:00-3:10 PM Speaker - Dr. Rupa Sanghani
END Drinks, Networking, and Hors d’oeuvres Reception / Conclusion & Poster Awards – Dr. Tochukwu Okwuosa Closing Remarks